Figure 3.
Kaplan-Meier plots of PFS and OS. Kaplan-Meier plots of PFS for overall cohort C population (N = 40) (A), patients with prior CAR-T therapy (B), and patients with prior ADC therapy (C) and OS for overall cohort C population (N = 40) (D), patients with prior CAR-T therapy (E), and patients with prior ADC therapy (F). The mPFS was 4.5 months (95% CI, 1.3-11.6) in panel A. Among patients who received prior CAR-T, the mPFS was 4.4 months (95% CI, 0.9-15.2) in panel B, and in patients who received prior ADC, the mPFS was 7.3 months (95% CI, 1.3-16.0) in panel C. The median OS was 15.5 months (95% CI, 8.3-27.9) in panel D. Among patients who received prior CAR-T, the median OS was 14.9 months (95% CI, 3.4-NE) in panel E, and in patients who received prior ADC, the median OS was 16.0 months (95% CI, 7.9 to NE) in panel F.

Kaplan-Meier plots of PFS and OS. Kaplan-Meier plots of PFS for overall cohort C population (N = 40) (A), patients with prior CAR-T therapy (B), and patients with prior ADC therapy (C) and OS for overall cohort C population (N = 40) (D), patients with prior CAR-T therapy (E), and patients with prior ADC therapy (F). The mPFS was 4.5 months (95% CI, 1.3-11.6) in panel A. Among patients who received prior CAR-T, the mPFS was 4.4 months (95% CI, 0.9-15.2) in panel B, and in patients who received prior ADC, the mPFS was 7.3 months (95% CI, 1.3-16.0) in panel C. The median OS was 15.5 months (95% CI, 8.3-27.9) in panel D. Among patients who received prior CAR-T, the median OS was 14.9 months (95% CI, 3.4-NE) in panel E, and in patients who received prior ADC, the median OS was 16.0 months (95% CI, 7.9 to NE) in panel F.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal